RxDoctor Payments Data

Alan Curtis, MD

Orthopaedic Surgery · Waltham, MANPI 1952369894

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (57.8%), ownership interests and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Zimmer Biomet at 53.9% of the total. Reporting peaked in 2023 at $101,069 and has fallen 94.4% since, to $5,640 in 2025. Among orthopaedic surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$184,448in general payments, 2019–2025

Across 96 payments — averaging $1921.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$99K
  • Anika Therapeutics, Inc.$65K
  • Arthrex$12K
  • Depuy Synthes Products, Inc.$4K
  • Kairos Surgical Inc$1K
  • Stryker$974
  • plus $2K from 14 others
$106,016in ownership & investment interests, 2019–2025

Across 5 payments — averaging $21,203 each. An ownership or investment interest held by the physician or an immediate family member.

  • Zimmer Biomet$106K
  • Parcus Medical, LLC$0
  • Embody, Inc.$0

What the payments were for

  • Consulting fees$15,6638%
  • Travel & lodging$1,3811%
  • Food & beverage$3,7962%
  • Ownership interest$57,05631%
  • Other$106,55358%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$184,448 in reported general payments places this provider in the 95th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$138,991
Medicare patients
405
Services billed
819

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone33$209
Meloxicam16$98

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Waltham

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →